Partner
CurrentPatrick Oot is a diverse, Chambers-ranked Band 1 litigator and globally recognized practice leader in pre-trial litigation and government investigations. He is ranked by Who’s Who Legal as a global “Thought Leader” and is at the top of the very short list of practitioners who clients seek to lead coordinated efforts in high-stakes MDL, class action, mass-tort, product liability and deceptive practices litigation. Patrick co-chairs the firm’s Data and Discovery Strategies Practice, ranked a Tier 1 practice by Legal 500.Patrick represents and advises six of the world’s largest life sciences companies, three of the world’s largest financial services organizations, one of the world’s top-three retailers and one of the world’s largest airlines on litigation and investigative matters. Patrick serves on the Defense Steering Committee in the In Re: Zantac (Ranitidine) Products Liability Litigation MDL for GlaxoSmithKline. He is also presently a member of the national leadership team representing Gilead in the TDF Products Liability Litigation and as national coordinating counsel in the nationwide opioid litigation for IQVIA. He has also served as national coordinating discovery counsel in complex litigation, including for Sanofi in the Taxotere MDL and for Bayer in the Essure Products Liability Litigation. In his privacy practice, Patrick has successfully litigated, argued and shut down a class action involving the Stored Communications Act, Electronic Communications Privacy Act, California Invasion of Privacy Act and Right to Financial Privacy Act.